Common Bacterial Infections in Newborns: Group B Strep and E. Coli Examples
Recent Trends
Over the past decade, universal screening for Group B Streptococcus (GBS) in late pregnancy has become standard in many regions, leading to a notable decline in early-onset GBS disease. However, new data from neonatal networks indicate a gradual rise in late-onset GBS cases, often linked to community-acquired strains. Meanwhile, Escherichia coli has emerged as the leading cause of early-onset sepsis among preterm infants, partly due to increasing maternal antibiotic use that may alter vaginal flora.
- GBS remains the most common cause of sepsis and meningitis in term newborns in high-income settings.
- E. coli accounts for roughly one-third of early-onset neonatal infections in very low birth weight infants.
- Antimicrobial resistance patterns, especially in extended-spectrum beta-lactamase (ESBL) producing E. coli, are being monitored closely.
Background
Group B Streptococcus is a bacterium that typically colonizes the gastrointestinal and reproductive tracts of about one in four pregnant women. During labor, it can be transmitted to the newborn, causing pneumonia, sepsis, or meningitis. E. coli, normally present in the gut, can cause similar infections, often with a more severe course in preterm babies.
- GBS: Early-onset (within first week) and late-onset (up to three months). Prevented with intrapartum antibiotics.
- E. coli: Most often acquired from the mother’s birth canal or from hospital settings; linked to urinary tract infections during pregnancy.
User Concerns
New parents often worry about subtle signs—fever, lethargy, poor feeding, irritability—that may indicate infection. Many ask about the reliability of screening tests and whether C-sections reduce risk. Pediatricians note that even with negative GBS screening, rare cases can occur, and E. coli infections are not routinely screened for prenatally.
- When to seek immediate medical help: temperature instability, grunting, unusual cry, or jaundice.
- Risk factors: preterm delivery, prolonged rupture of membranes, maternal fever during labor.
- Differences between GBS and E. coli infections are often indistinguishable without culture results.
Likely Impact
Prompt treatment with broad-spectrum antibiotics effectively resolves most GBS and E. coli infections. However, neonatal meningitis can lead to long-term neurodevelopmental challenges—hearing loss, seizure disorders, or motor delays—in a small percentage of survivors. Mortality rates for E. coli sepsis are higher among very premature infants, while GBS case fatality has dropped below 5% in areas with robust screening programs.
Economic and family impacts include extended hospitalization, follow-up care, and potential developmental surveillance. Antibiotic stewardship efforts aim to balance prevention with minimizing exposure to unnecessary drugs, which may reduce hospital-acquired E. coli resistance.
What to Watch Next
- Maternal GBS vaccine trials: Several candidates are in advanced stages, which could reduce reliance on intrapartum antibiotics.
- Changes in E. coli resistance patterns: Rising rates of ESBL-producing strains in some neonatal units may prompt adjustments in empiric therapy.
- Refinement of screening criteria: Risk-based vs. universal GBS screening remains debated for low-prevalence populations.
- New molecular diagnostics: Rapid PCR panels are increasingly used to identify pathogens within hours, guiding targeted treatment.
Future guidelines are expected to incorporate local epidemiology and antibiotic susceptibility data, moving beyond one-size-fits-all protocols.